Browse > Article
http://dx.doi.org/10.5125/jkaoms.2011.37.6.535

Temporomandibular joint involvement in malignant otitis externa: a case report  

Byun, In-Young (Department of Oral and Maxillofacial Surgery, National Health Insurance Corporation Ilsan Hospital)
Kim, Jin-Hong (Department of Oral and Maxillofacial Surgery, National Health Insurance Corporation Ilsan Hospital)
Kang, Sang-Hoon (Department of Oral and Maxillofacial Surgery, National Health Insurance Corporation Ilsan Hospital)
Kim, Moon-Key (Department of Oral and Maxillofacial Surgery, National Health Insurance Corporation Ilsan Hospital)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.37, no.6, 2011 , pp. 535-538 More about this Journal
Abstract
Malignant otitis externa (MOE) originates as inflammation of the epidermis in the external auditory canal, and spreads to the surrounding structures and neck, leading to abscess formation. MOE is associated with an immunosuppressive condition and diabetes. Patients with MOE suffer from otalgia, otorrhea and hearing loss. According to the literature, surgery to the temporomandibular joint is controversial as the treatment of choice.
Keywords
Otitis externa; Temporomandibular joint;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chandler JR. Malignant external otitis. Laryngoscope 1968;78: 1257-94.   DOI   ScienceOn
2 Mardinger O, Rosen D, Minkow B, Tulzinsky Z, Ophir D, Hirshberg A. Temporomandibular joint involvement in malignant external otitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:398-403.   DOI   ScienceOn
3 Nadol JB Jr. Histopathology of Pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol 1980;1:359-71.   DOI   ScienceOn
4 Naghibi M, Smith RP, Baltch AL, Gates SA, Wu DH, Hammer MC, et al. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res Clin Pract 1987;4:27-35.   DOI   ScienceOn
5 Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259-65.   DOI
6 Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR. Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis? Otolaryngol Head Neck Surg 1993;109:676-9.
7 Slattery WH 3rd, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am 1996;29:795- 806.
8 Bernheim J, Sade J. Histopathology of the soft parts in 50 patients with malignant external otitis. J Laryngol Otol 1989;103:366-8.   DOI
9 Singh A, Al Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg 2005;133:121-5.   DOI
10 Narozny W, Kuczkowski J, Stankiewicz C, Kot J, Mikaszewski B, Przewozny T. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 2006;263:680-4.   DOI   ScienceOn
11 Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V. Necrotizing external otitis: a report of 46 cases. Otol Neurotol 2007;28:771-3.   DOI   ScienceOn
12 Babiatzki A, Sade J. Malignant external otitis. J Laryngol Otol 1987;101:205-10.   DOI
13 Kwon BJ, Han MH, Oh SH, Song JJ, Chang KH. MRI findings and spreading patterns of necrotizing external otitis: is a poor outcome predictable? Clin Radiol 2006;61:495-504.   DOI   ScienceOn